Navigation Links
Botox(R) vs. Reloxin(R) -- the Wrinkle Titans Poised for Battle

NORTH DALLAS, Texas and PLANO, Texas, April 13 /PRNewswire/ -- Botox's arch-nemesis, Reloxin(R), is expected to meet Botox(R) wrinkle-to-wrinkle in the U.S. cosmetics ring at any moment; whether U.S. injectors will readily embrace this new and slightly unfamiliar European cousin remains to be seen, but the incentive to, in the way of a significant potential cost savings, is certainly provocative.


In this corner: An aesthetics golden-boy, with an excellent record of patient safety and reliable results; Botox(R) has earned its bragging rights, currently dominating the U.S. aesthetics market -- the uncontested champion hands-down in numbers of procedures performed against all other cosmetic treatments, surgical and non-surgical.

In the far corner: Already popular outside of the U.S. under the name Dysport(R), fans claim that Reloxin(R) lasts longer, is stronger, and can produce more natural-looking results than Botox(R). But what makes Reloxin(R) a triple-threat to Botox(R) is that, once mixed to the proper injection strength, Reloxin(R) should cost U.S. cosmetic physicians less than what they're currently paying for Botox(R). Will the U.S. champion wrinkle-reducer be able to hold its ground against this foreign brute?

Doctors who have worked extensively with both Botox(R) and Reloxin(R) (Dysport(R)) have reported that while the two are relatively comparable at their relative dilutions, injectors tend to prefer one over the other for various facial areas, due to differences in the onset of, and spread of effect. Reloxin(R) is decidedly faster-acting and has a greater 'spread'; while Botox tends to remain more localized, allowing for greater precision and predictability in the treatment area, but may require more injections during a treatment.

At first glance, a cheaper, stronger, longer-lasting wrinkle relaxer seems like a steal-of-a-deal, but at least a portion of the cost savings of Reloxin(R) will likely evaporate in the form of processing time, as doctors and staff will need to, at least initially, downshift to a much lower gear, taking additional precautions to ensure proper mixing ratio, optimal patient safety and favorable results. Beyond the obvious, intangibles such as the higher skill-set suggested (a comprehensive understanding of internal facial musculature and physiology) and an elevated risk potential (using a stronger toxin with a different mixing ratio and slightly varied treatment response) are considerations for an eager cosmetic injector to factor in. Whether cost savings to the practice ultimately will find their way to the cosmetic patient will likely correspond most directly to an injector's comfort level with Reloxin(R) and their ability to integrate it seamlessly into their regular daily workflow.

Jeffrey Adelglass, M.D., F.A.C.S., a cosmetic physician and Medical Director of SKINTASTIC Medical and Surgical Rejuvenation Center of Plano, who is currently one of the largest purchasers/injectors of Botox in North Texas and the U.S., offers a sobering piece of advice to those who may soon hear about Reloxin(R) deals offered at their local hair-and-nail salon or strip-mall shopping center: "With injectable cosmetic treatments (as with many things in life), if you see an offer that seems too good to be true, do a little digging to find out why it's so inexpensive. Sometimes it really is a quality offer by an established medical practice with injections performed by experienced, qualified medically-licensed injectors; but a super-discounted cosmetic injectable price can also be reflective of exactly the opposite: an injector's lack of qualifications, training and experience, and in some cases--inferior (super-diluted) or even counterfeit products."

Dr. Adelglass also stresses that establishing that your cosmetic injector has the right credentials and training will be more important than ever when it comes to Reloxin(R). "It is suggested that Reloxin(R) results might last up to a month or even two beyond that of Botox(R) - which could be a real bonus as long as the outcome is what you wanted; but if not, you'll have that much longer to live with the results."

Experience counts. Jeffrey Adelglass, M.D., F.A.C.S. was the first Texas physician to recently achieve simultaneous Diamond pinnacle-level status as a Botox(R) injector and Triple-Platinum status with Medicis, the makers of Restylane(R) and Perlane(R) injectable fillers. Dr. Adelglass is a member of the Star Program -- a group of cosmetic physicians specially-trained to work with Evolence(R), and an exclusive Black Card member of Radiesse(R) physician injectors. He serves on the scientific advisory boards of most, if not all U.S. dermal filler companies, and on the National Education Foundation for Allergan, instructing other cosmetic physicians to safely administer Botox(R) using his well-honed injection techniques. Dr. Adelglass is also an official training instructor for SmartLipo(TM) laser body sculpting, the DOT Fractional skin resurfacing laser, ArteFill(R) and Juvederm(R) dermal fillers. With his level of experience, it's no wonder that many of the representatives of these companies, with all their available options, select Dr. Adelglass as their own cosmetic physician of choice.

Call (972) 620-3223 to be added to a waiting list to receive a complimentary Reloxin(R) evaluation (and to receive a special introductory offer). Reloxin(R)-related questions can also be directed to Dr. Adelglass at Skintastic is located in the Presb

SOURCE Jeffrey Adelglass, M.D., F.A.C.S.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
2. AAFPRS Speaks to the Safety of BOTOX(R) Cosmetic
3. GFX: Wrinkle-Killer or Botox(R) Hit-Man?
4. Cougars Crave Biocap, The Haute Pepper Wrinkle Eraser
5. New Study Provides Scientific Evidence That DermaLastyl Face Cream Reduces Wrinkles
6. Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles
7. FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles
8. Grassini & Wrinkle Law Firm Are Awarded Largest PI Verdict in Ventura County History
9. New Medical Technology is Changing the Face of Wrinkle Treatment
10. Another new wrinkle in treating skin aging
11. Clinical Trial Concluded For New Wrinkle Treatment
Post Your Comments:
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... a real-time eReferral system for diagnostic imaging in the Waterloo region. Using the ... and Nuclear Medicine tests directly from their electronic medical record (EMR) without the ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... ... 2015 , ... PRMA Plastic Surgery is updating their record books yet again ... free flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, says ... and it’s an honor to have served all of these women.” , PRMA is ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings ... with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired ... font, giving users limitless opportunities to stylize and create designs quickly and easily, ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor ... application server to improve system efficiency and reliability. , The new Q-Suite 6 platform ... standards, the system avoids locking itself into a specific piece of software for many ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Países Bajos, November 26, 2015 ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... enfoque combina la inmunoterapia con la terapia fotodinámica de ... Clinical Cancer Research . --> Clinical Cancer ...
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 2015 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ... demands kidney transplantation is expected to boost the market growth, ... organ transplantation. --> 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ...
Breaking Medicine Technology: